abstract |
The present invention requires treatment by topically administering an effective amount of a composition of brimonidine or a pharmaceutically acceptable salt thereof and oxymetazoline or a pharmaceutically acceptable salt thereof to an affected area of a patient's skin. The present invention relates to a method for treating a dermatological disease or a symptom thereof. Furthermore, the present invention relates to a topical composition comprising said composition with a compound and a pharmaceutically acceptable carrier. |